Facebook tracking pixel
S10.AI
ICD-10-CM · B20GeneralSystemic

AIDS

Find comprehensive information on AIDS, also known as Acquired Immunodeficiency Syndrome and HIV Disease. This resource covers essential aspects of AIDS diagnosis, including clinical documentation, medical coding, ICD codes, healthcare guidelines, and HIV testing. Learn about the stages of HIV infection, treatment options, and preventative measures. Access valuable resources for healthcare professionals, patients, and researchers seeking reliable information on AIDS and HIV management.

Also known as
Acquired Immunodeficiency SyndromeHIV Disease
Definition

Late stage HIV infection severely weakening the immune system, increasing risk of opportunistic infections and cancers.

Clinical signs

Frequent infections, rapid weight loss, persistent fever, swollen lymph nodes, fatigue, diarrhea.

Common settings

HIV clinics, infectious disease departments, primary care settings, hospitals.

Related Codes

ICD-10 Code Families

Complete code families applicable to B20

B20-B24
Human immunodeficiency virus [HIV] disease
B25-B27
Cytomegaloviral disease
B35-B49
Mycoses
R75
Abnormal immunological function, unspecified
Code Comparison

When to use each related code

DescriptionWhen to use
Advanced HIV infection causing severe immune deficiency.Use for confirmed cases meeting CDC criteria for AIDS. Consider stage 3 HIV infection if criteria not met. HIV/AIDS
HIV infection not progressed to AIDS. Immune system may be weakened.Use for documented HIV infection not meeting AIDS criteria. Specify clinical stage if known. HIV infection
Initial stage of HIV, often asymptomatic. Highly infectious.Use for recent HIV infection, especially within weeks of exposure. Include if acute retroviral syndrome present. Acute HIV
Documentation

Best-practice checklist

  • AIDS diagnosis documentation checklist:
  • 1. Confirm HIV infection status (e.g., positive antibody/antigen test).
  • 2. Document CD4 count or percentage, if available.
  • 3. Specify any AIDS-defining illnesses (e.g., opportunistic infections).
  • 4. Record current treatment regimen (e.g., ART medications).
  • Keywords: AIDS, HIV, Acquired Immunodeficiency Syndrome, HIV Disease, diagnosis, documentation, medical coding, opportunistic infections, CD4 count, antiretroviral therapy, ART
Coding & Audit Risks

Common pitfalls to avoid

Unspecified HIV Stage

Coding AIDS without specifying stage (e.g., B20 vs B24) leads to inaccurate severity reflection and reimbursement.

HIV vs AIDS Misdiagnosis

Incorrectly coding HIV infection (B20) as AIDS (B24) or vice versa can impact quality reporting and care plans.

Opportunistic Infection Coding

Failing to code related opportunistic infections alongside AIDS can underestimate patient complexity and resource utilization.

Mitigation

Best-practice tips

  • 01HIV testing ICD-10 Z11.4, early ART initiation for AIDS Z21
  • 02CDI: Document opportunistic infections, ART adherence, CD4 count
  • 03Monitor viral load, adhere to CDC guidelines for HIV prevention
  • 04Healthcare compliance: Ensure patient confidentiality, informed consent
  • 05ICD-10 B20: Document HIV-related malignancies, code comorbidities
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm HIV infection via serology/molecular testing (ICD-10: B20)

  2. 2

    CD4 count <200 cells/mm3 or AIDS-defining illness present (SNOMED: 36330001)

  3. 3

    Document opportunistic infections or malignancies (ICD-10: B20.2, B20.3)

  4. 4

    Review patient history for risk factors (e.g., unprotected sex, IV drug use)

  5. 5

    Assess for and manage related complications (e.g., infections, malignancies)

Documentation Template

Ready-to-paste narrative

Patient presents with signs and symptoms suggestive of Acquired Immunodeficiency Syndrome (AIDS), also known as HIV disease.  The patient's chief complaint includes [specific chief complaint, e.g., persistent cough, unexplained weight loss, recurrent infections].  Review of systems reveals [list pertinent positive and negative findings, e.g., fatigue, night sweats, lymphadenopathy, oral thrush, Kaposi's sarcoma].  Past medical history includes [relevant past diagnoses, e.g., HIV infection, opportunistic infections].  Current medications include [list current medications, including antiretroviral therapy if applicable].  Physical examination findings include [document specific findings, e.g., decreased breath sounds, palpable lymph nodes, skin lesions].  Laboratory results show [include CD4 count, HIV viral load, and other relevant lab values].  Based on the patient's clinical presentation, laboratory findings, and meeting the CDC diagnostic criteria for AIDS (CD4 count below 200 cells/mm3 or presence of AIDS-defining illness), the diagnosis of Acquired Immunodeficiency Syndrome is confirmed.  Differential diagnoses considered include [list relevant differential diagnoses, e.g., other immunodeficiency disorders, malignancies].  Plan of care includes initiating/continuing antiretroviral therapy (ART),  prophylaxis for opportunistic infections as indicated, nutritional counseling, and close monitoring of CD4 count and HIV viral load.  Patient education provided regarding disease management, medication adherence, and importance of follow-up appointments.  ICD-10 code B20 assigned.  Referral to infectious disease specialist recommended for ongoing HIV care management.
FAQs

Common questions and answers

What are the most recent CDC guidelines for pre-exposure prophylaxis (PrEP) to prevent HIV acquisition in adolescents and young adults, and how can clinicians effectively implement these recommendations in a busy practice?+

The CDC's updated clinical practice guidelines for PrEP emphasize individualized risk assessment and shared decision-making with adolescents and young adults. These guidelines recommend offering PrEP to individuals with behavioral risk factors such as inconsistent condom use or having partners with known HIV. Clinicians can effectively implement these recommendations by incorporating routine sexual health assessments into primary care visits, utilizing validated risk assessment tools, and streamlining the PrEP prescription and monitoring process. Consider implementing a standardized PrEP workflow within your electronic health record system to facilitate efficient patient management and improve adherence. Explore how point-of-care testing and telehealth strategies can enhance access to PrEP services, especially for those in underserved communities. Learn more about the CDC's PrEP resources for clinicians to stay updated on the latest recommendations and best practices.

How can clinicians differentiate between acute HIV infection and other common viral syndromes, considering the overlapping symptoms and the importance of early diagnosis for effective antiretroviral therapy (ART) initiation?+

Acute HIV infection, also known as acute retroviral syndrome (ARS), often mimics other common viral illnesses like influenza or mononucleosis, making clinical diagnosis challenging. Key features that may suggest acute HIV include fever, lymphadenopathy, pharyngitis, rash, myalgia, and fatigue. However, these symptoms are non-specific. A high index of suspicion is crucial, particularly in patients with known risk factors. Rapid HIV testing should be performed in any patient presenting with compatible symptoms and a recent exposure history. If the initial rapid test is negative, and acute HIV is still suspected based on clinical presentation and risk assessment, a follow-up HIV RNA test is recommended. Early diagnosis is critical as immediate initiation of ART during acute HIV infection has shown significant benefits in preserving immune function and reducing long-term morbidity. Learn more about the clinical manifestations and diagnostic approaches for acute HIV infection to improve early detection and treatment.

What are the best strategies for managing treatment-resistant HIV in patients with long-standing infection, considering the complexities of multi-drug resistance and the importance of adherence support?+

Managing treatment-resistant HIV requires a comprehensive approach involving genotypic resistance testing to guide tailored antiretroviral therapy (ART) regimens. Clinicians should consider factors like prior treatment history, drug-drug interactions, and patient comorbidities when selecting a salvage regimen. Adherence counseling is paramount, as suboptimal adherence is a major driver of drug resistance. Explore how motivational interviewing techniques and support systems can improve adherence to complex ART regimens. Consultation with an HIV specialist is often warranted for patients with multi-drug resistance. Consider implementing integrated care models that combine medical, psychosocial, and mental health services to address the multifaceted challenges faced by patients with long-standing HIV infection and treatment resistance. Explore the latest research on novel antiretroviral agents and treatment strategies for drug-resistant HIV to enhance patient outcomes.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.